Viewing Study NCT01728220

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-02-24 @ 1:11 PM
Study NCT ID: NCT01728220
Status: COMPLETED
Last Update Posted: 2023-02-27
First Post: 2012-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
Sponsor: Bellerophon Pulse Technologies
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Hypertension View
None Chronic Obstructive Pulmonary Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Inhaled nitric oxide (iNO) View
None Pulmonary hypertension (PH) View
None Chronic obstructive pulmonary disease (COPD) View
None Long term oxygen therapy (LTOT) View